Literature DB >> 27345155

Mechanistic insights into mitral regurgitation due to atrial fibrillation: "Atrial functional mitral regurgitation".

Jackson J Liang1, Frank E Silvestry2.   

Abstract

Mitral regurgitation (MR) is common, and definitive management of significant MR often requires percutaneous or surgical correction. Lone atrial fibrillation has been proposed to result in "atrial functional mitral regurgitation (AFMR)" via left atrial enlargement and mitral annular dilation. Patients with AFMR may represent a subgroup in which a rhythm control strategy may be preferred and catheter ablation is a promising nonsurgical therapy. This review discusses the anatomy of the mitral valve apparatus and MR classification schemes. Potential mechanisms in the pathogenesis of AFMR the implications for treatment will be discussed in detail.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Atrial functional mitral regurgitation; Functional mitral regurgitation; Left atrium; Mitral annulus; Mitral regurgitation

Mesh:

Substances:

Year:  2016        PMID: 27345155     DOI: 10.1016/j.tcm.2016.04.012

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  7 in total

1.  Insights into functional mitral regurgitation using the average pixel intensity method.

Authors:  Victor Kamoen; Milad El Haddad; Tine De Backer; Marc De Buyzere; Frank Timmermans
Journal:  Int J Cardiovasc Imaging       Date:  2018-12-03       Impact factor: 2.357

Review 2.  Treatment of Functional Mitral Regurgitation in Heart Failure.

Authors:  Enrico Fabris; Antonio De Luca; Giancarlo Vitrella; Davide Stolfo; Marco Masè; Renata Korcova; Marco Merlo; Serena Rakar; Arnoud W J Van't Hof; Elvin Kedhi; Andrea Perkan; Gianfranco Sinagra
Journal:  Curr Cardiol Rep       Date:  2019-11-16       Impact factor: 2.931

3.  Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.

Authors:  Hongju Zhang; Edward A El-Am; Jeremy J Thaden; Sorin V Pislaru; Christopher G Scott; Chayakrit Krittanawong; Anwar A Chahal; Thomas J Breen; Mackram F Eleid; Rowlens M Melduni; Kevin L Greason; Robert B McCully; Maurice Enriquez-Sarano; Jae K Oh; Patricia A Pellikka; Vuyisile T Nkomo
Journal:  Heart       Date:  2019-08-22       Impact factor: 5.994

Review 4.  Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction.

Authors:  Jackson J Liang; David J Callans
Journal:  Card Fail Rev       Date:  2018-05

Review 5.  Mitral valve interventions in heart failure.

Authors:  Daniel Lavall; Andreas Hagendorff; Stephan H Schirmer; Michael Böhm; Michael A Borger; Ulrich Laufs
Journal:  ESC Heart Fail       Date:  2018-04-19

6.  The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.

Authors:  Andrew J S Coats; Stefan D Anker; Andreas Baumbach; Ottavio Alfieri; Ralph Stephan von Bardeleben; Johann Bauersachs; Jeroen J Bax; Serge Boveda; Jelena Čelutkienė; John G Cleland; Nikolaos Dagres; Thomas Deneke; Dimitrios Farmakis; Gerasimos Filippatos; Jörg Hausleiter; Gerhard Hindricks; Ewa A Jankowska; Mitja Lainscak; Christoph Leclercq; Lars H Lund; Theresa McDonagh; Mandeep R Mehra; Marco Metra; Nathan Mewton; Christian Mueller; Wilfried Mullens; Claudio Muneretto; Jean-Francois Obadia; Piotr Ponikowski; Fabien Praz; Volker Rudolph; Frank Ruschitzka; Alec Vahanian; Stephan Windecker; Jose Luis Zamorano; Thor Edvardsen; Hein Heidbuchel; Petar M Seferovic; Bernard Prendergast
Journal:  Eur Heart J       Date:  2021-03-18       Impact factor: 29.983

Review 7.  Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure.

Authors:  Nathan C Denham; Charles M Pearman; Jessica L Caldwell; George W P Madders; David A Eisner; Andrew W Trafford; Katharine M Dibb
Journal:  Front Physiol       Date:  2018-10-04       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.